---
annotations:
- type: Pathway Ontology
  value: coagulation cascade pathway
authors:
- MaintBot
- Khanspers
- Ariutta
- ReactomeTeam
- Anwesha
- Mkutmon
description: The formation of a fibrin clot at the site of an injury to the wall of
  a normal blood vessel is an essential part of the process to stop blood loss after
  vascular injury.  The reactions that lead to fibrin clot formation are commonly
  described as a cascade, in which the product of each step is an enzyme or cofactor
  needed for following reactions to proceed efficiently.  The entire clotting cascade
  can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
  and the common pathway.  The extrinsic pathway begins with the release of tissue
  factor at the site of vascular injury and leads to the activation of factor X.  The
  intrinsic pathway provides an alternative mechanism for activation of factor X,
  starting from the activation of factor XII.  The common pathway consists of the
  steps linking the activation of factor X to the formation of a multimeric, cross-linked
  fibrin clot.  Each of these pathways includes not only a cascade of events that
  generate the catalytic activities needed for clot formation, but also numerous positive
  and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1818
- /instance/WP1818
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1818.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The formation of a fibrin clot at the site of an injury to the wall
    of a normal blood vessel is an essential part of the process to stop blood loss
    after vascular injury.  The reactions that lead to fibrin clot formation are commonly
    described as a cascade, in which the product of each step is an enzyme or cofactor
    needed for following reactions to proceed efficiently.  The entire clotting cascade
    can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
    and the common pathway.  The extrinsic pathway begins with the release of tissue
    factor at the site of vascular injury and leads to the activation of factor X.  The
    intrinsic pathway provides an alternative mechanism for activation of factor X,
    starting from the activation of factor XII.  The common pathway consists of the
    steps linking the activation of factor X to the formation of a multimeric, cross-linked
    fibrin clot.  Each of these pathways includes not only a cascade of events that
    generate the catalytic activities needed for clot formation, but also numerous
    positive and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
    Reactome].
  keywords:
  - kallikrein:alpha2-macroglobulin
  - 'thrombin heavy chain '
  - factor XII
  - precursor
  - SERPIND1
  - protein C
  - 'F12 T328R '
  - PalmC-F3
  - 'bivalirudin '
  - Zn2+
  - A2M tetramer
  - 'thrombin light chain '
  - TF:F7
  - PROCR:Protein C
  - Extracellular
  - factor IXa
  - VIII
  - F5(535-737)
  - FVIIIa:FIXa:PROS1
  - fibrin monomer
  - activation peptide
  - PROC(200-211)
  - factor VIIa
  - 'factor XIII A chain '
  - (329-615)
  - (compounds)
  - 'F13B '
  - factor XIII
  - Factor IIa
  - 'FGB(31-491) '
  - PROCR:Activated
  - 'KLKB1(20-638) '
  - factor VIIIa A1
  - 'KLKB1(20-390) '
  - SERPINE2:GAG
  - 'PROC(200-461) '
  - inactivating
  - 'factor VIII light chain '
  - (factor
  - kininogen:C1q
  - F12 variant (20-328)
  - factor X activation
  - 'GP1BB '
  - 'F9(227-461) R384L '
  - 'F8(20-355) '
  - FVIIIa:FIXa R384L
  - PRTN3:CD177
  - multimer
  - binding protein
  - 'TFPI '
  - 'factor VIIIa A3 C1 C2 polypeptide '
  - prekallikrein:kininogen:C1q binding protein tetramer
  - F2R
  - (peptide)
  - 'FGA '
  - 'factor VIIa heavy chain '
  - 11xCbxE-PROS1
  - factor VIIIa B A3
  - thrombin:SERPINC1:SERPINC1 activators
  - 'F12 T328K(20-328) '
  - SERPINA5:Activated
  - 'factor XIIIa A chain '
  - 'factor Va light chain '
  - 10xCbxE-F7(61-466):Ca2+
  - factor
  - 'FGA(20-866) '
  - PROCR(18-?)
  - fibrin multimer
  - 'factor VIIIa A1 polypeptide '
  - 'F8(392-759) R717L '
  - factor Va
  - 'F8(20-391) S308L '
  - F12 variant
  - factor Xa
  - 'factor XIa heavy chain '
  - 'F12 T328R(20-328) '
  - thrombin
  - NH4+
  - 'F8(20-391) A303E '
  - 'GP1BA '
  - intermediate form
  - factor XIIa:C1Inh
  - C:Protein S
  - 'factor IXa heavy chain '
  - activators
  - FGB(31-44)
  - IIa):SERPIND1
  - Inactivated factor
  - prolylcarboxypeptidase dimer
  - F8(582-640)
  - FGA(20-35)
  - inhibitors:IIa
  - Ca2+
  - 'factor XIIa light chain '
  - 'FGB '
  - factor V activation
  - activated
  - factor multimer
  - 'F12 T328R (373-615) '
  - 'C1QBP '
  - '8xCbxE-3D-PROC(43-197) '
  - 'F8(392-759) R550C '
  - (peptide):IIa
  - TFPI
  - A1:A3-C1-C2
  - Activated protein
  - PROCR(18-?):PRTN3:CD177
  - 'SERPINC1 '
  - 'factor XIa light chain '
  - '11xCbxE-3D-F10(41-179) '
  - PROCR(18-?):Activated protein C
  - 'VWF(764-2813) '
  - activated thrombin
  - F8(356-372)
  - 'KNG1(19-644) '
  - polypeptide
  - 'F8(373-581) '
  - (373-615)
  - kallikrein:kininogen:C1q binding protein tetramer
  - defective A1 domain
  - 'F12 T328K (373-615) '
  - 12xCbxE-3D-F9(47-461)
  - 'F12 T328R (329-615) '
  - 'PRCP '
  - XIa:GPIb:GPIX:GPV
  - 'SERPINC1(33-425) '
  - Activated protein C
  - 'PROCR '
  - 'F2R '
  - Va:Xa:Factor Xa
  - 'F8(392-759) N713I '
  - SERPINC1:SERPINC1
  - 'SERPINA5 '
  - (factor IIa)
  - variant:A3-C1-C2
  - tetramer
  - 'factor X heavy chain '
  - F13B
  - sequestered tissue
  - crosslinked
  - F5(335-534)
  - '10xCbxE-F7(61-212) '
  - factor V
  - inhibitors
  - Platelet Factor 4
  - Xa
  - factor Vi
  - TFPI:TF:F7a:factor
  - 'KLKB1(391-638) '
  - 'factor VIIIa A2 polypeptide '
  - 'PRTN3 '
  - KNG1(19-644)
  - von Willibrand
  - 10xCbxE-F2(44-622)
  - 'PF4V1(31-104) '
  - F9(29-461)
  - Fibrinogen
  - acidic polypeptide
  - factor XI
  - thrombin:thrombomodulin
  - C1q binding protein
  - 'F8(392-759) R717W '
  - factor VIII:von
  - complexes
  - 'factor XI monomer '
  - fibrin multimer,
  - 'KNG1(390-644) '
  - 'GP5 '
  - '10xCbxE-F7(61-466) '
  - 'F8(392-759) R550G '
  - factor XI:GPIb-IX-V
  - 'PROCR(18-?) '
  - PROCR
  - 'factor Xa heavy chain '
  - 'F5(29-334) '
  - defective A2 domain
  - factor XIII cleaved
  - peptide
  - Va:Xa
  - 'SERPIND1 '
  - 'PF4(32-101) '
  - thrombin:cleaved
  - 'factor XIIa heavy chain '
  - SERPINC1
  - TF:F7a
  - factor XIIa
  - 'PalmC-F3 '
  - SERPING1
  - factor VIII
  - GPIb-IX-V
  - 10xCbxE-F2(44-327)
  - domain variant
  - Factor Xa inhibitors
  - KLKB1(20-638)
  - 'F5(29-534) '
  - THBD
  - 'factor VIII heavy chain '
  - GAG
  - KNG:C1q binding
  - '11xCbxE-PROS1 '
  - 'CD177 '
  - 'FGG '
  - protein tetramer
  - Factor VIII
  - 'GAG '
  - IXa
  - factor XIII A chain
  - factor XIIIa
  - kallikrein:C1Inh
  - 'F12 T328K (329-615) '
  - 'SERPINE2 '
  - 'PROC(212-461) '
  - 'apixaban '
  - factor VIIIa
  - 'dalteparin '
  - Protein C
  - F8(392-759) A2
  - 'A2M '
  - SERPINC1 activators
  - factor VIIIa:factor
  - 'SERPINC1(426-464) '
  - SERPINA5
  - factor X
  - 'SERPING1 '
  - factor VIIIa A2
  - Willebrand factor
  - 'F8(392-759) R550H '
  - 'argatroban '
  - 'GP9 '
  - factor VIIIa with
  - '12xCbxE-3D-F9(47-191) '
  - complex
  - Bradykinin
  - (compounds):IIa
  - factor Xa:Factor Xa
  - 'F12 T328K '
  - 'KNG1(19-380) '
  - factor IX activation
  - SERPINE2:GAG:activated thrombin (factor IIa)
  - protein C:F2R
  - Plasma kallikrein
  - 'factor Va heavy chain '
  - 'THBD '
  - 'Ca2+ '
  license: CC0
  name: Formation of Fibrin Clot (Clotting Cascade)
seo: CreativeWork
title: Formation of Fibrin Clot (Clotting Cascade)
wpid: WP1818
---